Why the study?
What are the clinical implications and risks of venous thrombosis and arterial disease associated with combined oral contraceptive pills?
What are the clinical implications and risks of venous thrombosis and arterial disease associated with combined oral contraceptive pills?
This review highlights the importance of accurately communicating the reassessed risks of venous and arterial thrombosis associated with combined oral contraceptives to optimize clinical practice.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Angela M. Mills (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: